Home ABR–Affinity BioReagents

ABR–Affinity BioReagents

acquired
-
A company that develops chemicals

Basic Information

ABR - Affinity BioReagents manufactures and distributes monoclonal and polyclonal antibodies as well as recombinant proteins for the scientific research community. The company offers cell biology products, including those related to apoptosis, cell adhesion and junctions, structural markers, and cytokines; cell signaling products such as biologically active peptides, G protein-coupled receptors, kinases, membrane receptors, steroid receptors, and steroid hormones; controls, secondary antibodies, and tags including blocking peptides and secondary antibodies; and products in muscle biology, nuclear biology, neurobiology, and stem cell biology. It also provides reagents and immunology services.
ABR-Affinity BioReagents, Inc
United States of America
15~50 people
January 01, 1989
--